Clinical trial
Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised…
NCT00147355 · Kirby Institute, Other · Terminated
Key facts
| NCT number | NCT00147355 |
|---|---|
| Title | Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy |
| Official title | An Open-label, Randomised Study Comparing the Uptake of rIL-2 in HIV-1 Infected Individuals Receiving Different Combinations of Antiemetics and Analgesic Agents During rIL-2 Dosing in ESPRIT: Toxicity Substudy of ESPRIT: TOXIL-2 Substudy |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | The University of New South Wales |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | ondansetron, ibuprofen, paracetamol, Ondansetron, metoclopramide, Metoclopramide, codeine phosphate |
| Enrollment | 28 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 12, 2012 |
| Countries | Argentina, Australia, Israel |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: